|
|
Profile
|
Delegates :
Shin Yoshida |
|
Incorporated :
January 16 , 2024 |
Paid in Capital :
Million yen |
Employees :
人 |
Address :
Fujiimi Duplex B's 4F, 1-3-11 Fujimi, Chiyoda-ku TOKYO
〒102-0071
|
TEL/FAX :
/ |
URL：
https://www.gelcoatbio.com/en |
Attachment :
|
Mission/Background :
Gel Coat Biomaterials, Inc. is a University of Tokyo spin-off founded in 2024 based on the hydrogel technology invented by Prof. Madoka Takai. The company develops proprietary biomaterial technologies that stabilize enzymes, antibodies, nucleic acids, and other biological substances while preserving their functionality. Through its unique hydrogel platform, Gel Coat Biomaterials aims to create new value in biotechnology, healthcare, and sustainable manufacturing by enabling broader utilization of biological materials. |
|
Technology & Business
|
Gel Coat Biomaterials has developed Gel Coat(TM) a proprietary bio-compatible cell membrane mimicking hydrogel platform that stabilizes biological molecules while maintaining their activity. The technology enables enzymes and other biomolecules to function under harsh conditions such as high temperatures, long-term storage, and organic solvents. Applications include biomanufacturing, biopharmaceutical production, nucleic acid technologies, cell preservation, regenerative medicine, and medical devices. The company commercializes its technology through licensing agreements and collaborative R&D projects.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Gel CoatT（TM）Antifouling
|
Launched
|
An ultra-thin nano-coating treatment that prevents protein and biofouling.
|
Establishment of a mass production system and expansion of licensing opportunities.
|
Gel Coat（TM）IVD Solid State Stabilizer
|
Launched
|
A stabilization technology that improves the long-term storage life of biomolecules.
|
Establishment of a mass production system and expansion of licensing opportunities.
|
Gel Coat（TM）Bio Stabilizer
|
Discovery
|
A biomolecule stabilization platform extends their shelf life and broadens their applicable environments.
|
Establishment of a mass production system and expansion of licensing opportunities.
|
|
|
|
|
|
|
|
|
|
Highlights
|
We were selected for the Japan Pavilion at the 2026 BIO International Convention, actively advancing business collaborations with both domestic and international companies. Received an Award for our interfacial treatment technology at U-Start UP KANSAI 2026 (October 2026). Our biomolecule stabilization technology won the Grand Prize at the Biotech Grand Prix 2026 (TECH PLANTER) (October 2026).
|
|
Hot news
|
Our Gel Coat antifouling technology was released in July 2026. Gel Coat (TM) antifouling technology significantly reduces the maintenance costs and operational workloads associated with barnacle adhesion, machinery and pipe clogging, and stains such as mold.
Our bio-stabilization technology garnered attention and was featured in a Nikkei Biotech article in July 2026. It resolves critical pain points—such as the room-temperature degradation and aggregation of biomolecules.
|
|
Alliance strategy
|
Seeking Application Development Partners
Gel Coat (TM) Antifouling Technology: Reduces maintenance costs and operational workloads by preventing barnacle adhesion, machinery/pipe clogging, and mold.
Bio-Stabilization Technology: Enables new product development by solving major biomolecule pain points, including room-temperature degradation and aggregation.
|
|
|